Intraocular Melanoma [clinicaltrials_resource:b843293692adaa4c6c5ec09c08881553]
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002947]Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer [clinicaltrials:NCT00003022]Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00003339]Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [clinicaltrials:NCT00003802]Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005815]Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00005841]Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery [clinicaltrials:NCT00025181]Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma [clinicaltrials:NCT00027742]Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma [clinicaltrials:NCT00031733]Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00032045]Vaccine Therapy in Treating Patients With Melanoma of the Eye [clinicaltrials:NCT00036816]Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00058279]Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma [clinicaltrials:NCT00072345]clinicaltrials:NCT00084656Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [clinicaltrials:NCT00089206]clinicaltrials:NCT00089219FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma [clinicaltrials:NCT00104884]Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma [clinicaltrials:NCT00110123]PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma [clinicaltrials:NCT00238329]clinicaltrials:NCT00243061clinicaltrials:NCT00313508clinicaltrials:NCT00324727Vaccine Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00334776]clinicaltrials:NCT00398073clinicaltrials:NCT00445965clinicaltrials:NCT00471133clinicaltrials:NCT00471471clinicaltrials:NCT00482911Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma [clinicaltrials:NCT00489944]Vaccine Therapy in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00705640]clinicaltrials:NCT00738361Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom [clinicaltrials:NCT00757614]Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma [clinicaltrials:NCT00897624]Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye [clinicaltrials:NCT00952939]Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye [clinicaltrials:NCT01217398]
condition [clinicaltrials_vocabulary:condition]
Intraocular Melanoma [clinicaltrials_resource:b843293692adaa4c6c5ec09c08881553]
Bio2RDF identifier
b843293692adaa4c6c5ec09c08881553
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b843293692adaa4c6c5ec09c08881553
identifier
clinicaltrials_resource:b843293692adaa4c6c5ec09c08881553
title
Intraocular Melanoma
@en
label
Intraocular Melanoma [clinicaltrials_resource:b843293692adaa4c6c5ec09c08881553]
@en